• Research Compliance Program

    The mission of the Research Compliance Program (RCP) at Cincinnati Children’s Hospital Medical Center is:

    • To protect all of our research participants
    • To educate our investigators in the conduct of research that is safe, effective and in compliance with federal, state and institutional requirements
    • To maintain a comprehensive and integrated compliance program that is facilitative and educational for the research community and provides Cincinnati Children’s assurance that research is being conducted ethically and in compliance with the above requirements

    The RCP achieves this mission primarily through supporting the other program areas within ORCRA by providing the necessary and independent internal compliance auditing and investigation functions. The RCP also collaborates closely with ORCRA’s Research Education Program to identify and facilitate many of the institution’s research-related education and training needs.

    The Research Compliance Program consists of auditing and QA oversight for the following functional areas:

  • Audits are performed on studies of research involving human participants.  Audits serve two primary functions:  (1) to provide support to investigators in the process of research and (2) to identify difficulties with the conduct of research at the earliest possible moment to proactively institute individual and system level changes to ensure that all human subjects research is conducted to the highest ethical standards and in compliance with all applicable federal, state and institutional requirements.  

    How are studies chosen for audit?

    • Randomly − based on a list of approved studies within the IRB                              
    • Directed − requested by the IRB or CCTST for oversight
    • Investigation − resulting from an allegation or concern of noncompliance
    • Educational / process improvement − investigators request ORCRA to perform an audit of their study

    Regulations / Standards

    21 CFR 50 Protection of Human Subjects
    21 CFR 54 Financial Disclosure by Clinical Investigators
    21 CFR 56 Institutional Review Boards
    21 CFR 312 Investigational New Drug Application
    21 CFR 812 Devices
    45 CFR 46 Protection of Human Subjects (HHS)
    ICH E6: Good Clinical Practices

    Quality assurance oversight is provided for the areas of Cincinnati Children’s that are obligated to comply with these regulations including the Cancer and Blood Diseases Institute’s Translational Core laboratories: Cellular Manipulations Laboratory (CML), Vector Production Facility (VPF) and Translational Trials Development and Support Laboratory (TTDSL). 

    Regulations / Standards

    21 CFR 210 and 211 Good Manufacturing Practice
    21 CFR 1270 and 1271 Good Tissue Practice

    Quality oversight is provided for the areas of Cincinnati Children’s that are subject to these additional standards, including the following three laboratories at the Oak Campus: Laboratory for Specialized Clinical Studies (Division of Infectious Diseases), Central Laboratory (Division of Pathology and Laboratory Medicine) and Laboratory for Applied Pharmacokinetics and Therapeutic Drug Management (LAPTDM).  

    Regulations / Standards

    21 CFR 58 Good Laboratory Practice for Non-clinical Laboratory Studies

  • For additional information regarding the Cincinnati Children’s Research Compliance Program, including consultation regarding compliance planning or determining how to handle / manage compliance concerns, contact the ORCRA and ask to speak with the research compliance program director.

  • Educational Resources

    The Office of Research Compliance and Regulatory Affairs provides training programs, seminars and events that improve compliance with federal regulations and institutional policies governing research, while promoting research integrity and best practices for research professionals.

    Read More About Education Opportunities